Kevin Van Holsbeeck

6PUBLICATIONS
22CO-AUTHORS
Medical infection agents (incl. prions)BiomaterialsMolecular targetsPolymerisation mechanismsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 09, 2024
Structural basis of μ-opioid receptor targeting by a nanobody antagonist.

Jun Yu, Amit Kumar, Xuefeng Zhang

|Jul 07, 2023
Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria.

A Breine, K Van Holsbeeck, C Martin

|Apr 17, 2023
Nanobody Loop Mimetics Enhance Son of Sevenless 1-Catalyzed Nucleotide Exchange on RAS.

Kevin Van Holsbeeck, Baptiste Fischer, Simon Gonzalez

|Mar 23, 2023
Nature-Inspired Dual Purpose Strategy toward Cell-Adhesive PCL Networks: C(-linker-)RGD Incorporation via Thiol-ene Crosslinking.

Quinten Thijssen, Laurens Parmentier, Kevin Van Holsbeeck

|Dec 22, 2022
Propargylamine Amino Acids as Constrained Nε-Substituted Lysine Mimetics.

Kevin Van Holsbeeck, Mathias Elsocht, Steven Ballet

|May 08, 2019
Trifluoromethylated Proline Surrogates as Part of "Pro-Pro" Turn-Inducing Templates.

Charlène Gadais, Kevin Van Holsbeeck, Samuel L C Moors

Pageof 1